Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection

Clinical Trial ID NCT02978157

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02978157

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Helicobacter pylori infection. N Engl J Med 2002 14.81
2 Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012 12.62
3 Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010 4.43
4 Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009 3.88
5 Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009 3.18
6 Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010 2.50
7 Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol 2009 2.15
8 Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol 2006 1.83
9 Endoscopic 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Dig Liver Dis 2003 1.50
10 Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J Gastroenterol 2004 1.33
11 Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection. Scand J Gastroenterol 2001 1.25
12 Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol 1997 1.06
13 Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009 0.92
14 Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test. Dig Dis Sci 2001 0.92
15 Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection. Scand J Gastroenterol 2013 0.87
16 Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice. Dig Liver Dis 2010 0.85
17 Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations. Biol Pharm Bull 2002 0.83
Next 100